TORONTO, ON / ACCESSWIRE / January 20, 2021 / Kontrol Vitality Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) (“Kontrol” or “Business“), a leader in good properties and cities through IoT, Cloud and SaaS know-how, is delighted to announce that it carries on to progress the deployment of its BioCloud technology.
“We are delighted with the development we are generating with our distribution community, our direct buyers and numerous concentrations of Govt,” says Paul Ghezzi, CEO. “Through our developing distribution network, we have been offered with many likely prospects purposes. Most not long ago we have reviewed a variety of purposes for experienced and novice athletics.”
Non-Disclosure Arrangement (NDA)
BioCloud has entered into a Non-Disclosure Settlement, with a foremost clinical sports authority, to share the total scope of BioCloud’s patents and investigation. The intent of the NDA is to advance various opportunity activity programs. This kind of apps incorporate, but are not